Description
Bleokey 15 IU
Composition: Bleomycin 15,000 units
Classification: Anticancer Medicine
Bleokey 15 IU injection is widely used as a chemotherapy drug, available as a lyophilized powder equivalent to 15,000 units of bleomycin.
Aprazer’s Bleokey: A Global Standard in Oncology Care
With a scientifically backed formulation and WHO certification, Bleokey is highly acceptable to healthcare practitioners worldwide.
Committed to delivering affordable, life-saving therapeutics accessible to all, Aprazer Healthcare has gained global recognition, exporting to more than 20 countries.
Uses of Bleokey (Bleomycin)
Bleomycin Sulphate IP is considered a palliative treatment to surgery and radiation therapy.
Squamous tissue Carcinomas – head, neck, penis, uvula
Hodgkin’s lymphoma
Non-Hodgkin’s lymphoma
Pleural effusion, Malignant
Testicular Carcinoma- Embryonal cell, choriocarcinoma, and teratocarcinoma.
How does Bleokey work?
Bleomycin breaks DNA strands – Inhibits DNA replication- Induces apoptosis (cell death).
General side-effects
Fever, chills, vomiting, anorexia, malaise, and weight loss are common and may persist long after the termination of this medication.
Skin rash and pigmentation
Mouth Ulcers
GIT upset – nausea, vomiting, diarrhea
Anemia
Hair loss
Serious Side-effects
Renal toxicity
Hepatotoxicity
Pulmonary toxicity
Stability:
Bleokey lyophilized powder is stable when stored at 2° C (36º F) to 8° C (46º F).
The reconstituted solution of bleomycin in NACL is stable for 24 hours at room temperature.
Bleokey should not be reconstituted with D5W or other dextrose-containing diluents.
Potential Toxicities:
Pulmonary toxicity: Pulmonary Fibrosis is the most severe toxicity caused by bleomycin injection.
Precautions:
To be Cautiously Used In –
Patients with renal insufficiency
Pregnant/breastfeeding mothers
Warning:
Bleokey, containing bleomycin, is a prescription drug to be used under medical supervision with adequate diagnostic and treatment facilities available.
Important safety note:
To be used cautiously in people with hypersensitivity or idiosyncratic reactions to the drug and with renal insufficiency and impaired pulmonary function.
